The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|18|2074-2086

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.18, 2009-06, pp. : 2074-2086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microbiota Regulation of Inflammatory Bowel Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 1, 2014-02 ,pp. : 65-73

Bentham Science Publishers

Access to resources Recommend Favorite

The Gut Microbiota in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1528-1536

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: The Impact of Microbiota and Cytokines on Inflammatory Bowel Disease (Executive Editors: Osamu Kanauchi and Keiichi Mitsuyama)]

By  

Current Pharmaceutical Design, Vol. 15, Iss. 18, 2009-06 ,pp. : 2049-2050

Bentham Science Publishers

Access to resources Recommend Favorite

Current Therapeutic Approaches in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3668-3683

Bentham Science Publishers

Access to resources Recommend Favorite

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease

By Mitsuyama Keiichi   Sata Michio  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite